The median fold changes versus controls were similar and <1 for all t-tau assays (P = 0.076, Supplementary Table 6), and none of the t-tau and p-tau assays discriminated progressive supranuclear palsy from controls (AUCs 51–64% for all; Fig. 5B). The gene discussed is MAPT; the disease is progressive supranuclear palsy.